Xeris Pharmaceuticals (NASDAQ:XERS) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.30) by 36.67 percent. This is a 34.92 percent increase over losses of $(0.63) per
Companies Reporting Before The Bell
• OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.
Xeris Pharmaceuticals Inc (NASDAQ:XERS) has entered into an exclusive agreement with Tetris Pharma Limited to commercialize Ogluo in the European Economic Area, the…
Up to $71 million in time- and milestone-based payments, plus royalties on sales
Agreement covers 32 countries
First launch expected in Q4 2021 in UK
CHICAGO--(BUSINESS WIRE)-- Xeris Pharmaceuticals, Inc.
Gainers
DLocal Limited (NASDAQ: DLO) shares jumped 54.2% to close at $32.39 on Thursday. DLocal raised around $92.6 million from the sale of 4.4 million shares in its IPO.
Toward the end of trading Monday, the Dow traded up 0.75% to 34,462.98 while the NASDAQ rose 1.64% to 13,691.64. The S&P also rose, gaining 1.25% to 4,207.76.